| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8651824 | The American Journal of the Medical Sciences | 2018 | 19 Pages | 
Abstract
												Older patients with suspected PH often have significant cardiovascular and respiratory comorbidity. Comprehensive evaluations are needed to determine the severity of PH and associated diseases and to initiate treatment focused on FC. Patients in WHO Group 2 and mixed Group 2 and 3 were frequently identified and constituted a diagnostic and treatment challenge in this study. Older patients with PAH may benefit from PAH specific drugs.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Hawa MD, Kavitha MD, Tatiana MD, Terrance MD, Victor MD, Kenneth MD, 
											